BCL2 and neoplasm: PI3K-Akt-mTOR signaling pathway is frequently activated in gastric cancer patients, and can promote the release of free Bcl-2 from Bcl-2/Bcl-xl dimer, and promote the proliferation and growth of tumor [38].